Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort (Lancet Regional Health Europe, 2023)

(untitled) - Joy, M; Agrawal, U; Fan, X; Robertson, C; Anand, SN; Ordonez-Mena, J; Byford, R; Goudie, R; Jamie, G; Kar, D; Williams, J; Marsden, GL; et al.